Chinese biotech firm BeiGene Ltd on Thursday kicked off its initial public offering (IPO) subscription exercise on the Nasdaq-style STAR Market of the Shanghai Stock Exchange (SSE), with a target to …
( read original story …)
The Shanghai News
Chinese biotech firm BeiGene Ltd on Thursday kicked off its initial public offering (IPO) subscription exercise on the Nasdaq-style STAR Market of the Shanghai Stock Exchange (SSE), with a target to …
( read original story …)